• Assay Selection Tool

BellBrook Labs

  • Products
    • Transcreener® HTS Assays
      • Transcreener® ADP² Kinase Assay
      • Transcreener® ADO CD73 Assay
      • Transcreener® AMP²/GMP² Phosphodiesterase Assay
      • Transcreener® cGAMP cGAS Assay
      • Transcreener® GDP GTPase Assay Kits
      • Transcreener® UDP² Glycosyltransferase Assay
      • Transcreener® EPIGEN SAH Methyltransferase Assay
    • AptaFluor® HTS Assays
      • AptaFluor® SAH Methyltransferase Assay
    • HTS Assays by Target Family
      • Kinase Assay Kits
      • ATPase Assay Kits
      • Glycosyltransferase Assay Kits
      • GTPase Assay Kits
        • GAP Assay Kits
        • GEF Assay Kits
      • Methyltransferase Assay Kits
      • Ligase and Synthetase Assay Kits
      • Phosphodiesterase Assay Kits
    • HTS Assays by Target
      • AMPK Assay Kits
      • cGAS Assay Kits
      • CD39 Assay Kits
      • CD73 Assay Kits
      • ENPP1 Assay Kits
      • EZH2 Assay Kits
      • IKK-beta Assay Kits
      • IRAK4 Assay Kits
      • JAK1 Assay Kits
      • JAK3 Assay Kits
      • TBK1 Assay Kits
    • Recombinant cGAS Enzyme
      • Human cGAS Enzyme
      • Mouse cGAS Enzyme
    • Assay Plates
    • Ordering Information
  • Services
    • Assay Development Services
    • Lead Discovery Services
    • GTPase Profiling Services
  • Innate Immunity
    • cGAS Activity Assays
    • CD73 Activity Assays
    • CD39 Activity Assays
    • ENPP1 Activity Assays
    • IKK-beta Activity Assays
    • IRAK4 Activity Assays
    • JAK1 Activity Assays
    • JAK3 Activity Assays
    • TBK1 Activity Assays
  • Resources
    • Application Notes
    • Transcreener® Assays – Instrument Compatibility
    • Posters and Presentations
    • Publications
    • Technical Manuals
    • Transcreener® FAQ’s
    • Guides
      • Residence Time Guide
      • Hit Prioritization Guide
  • Company
    • President’s Message
    • International Distributors
    • Careers
    • Downloads
    • Contact Us
  • Blog
  • MY CART
    No products in cart.

Transcreener Assay Used to Help Discover CPS1 Inhibitor

by Bellbrook Labs / Tuesday, 12 May 2020 / Published in Success Stories
CPS1 Inhibitor Researcher at the Bench

Researchers look to discover a CPS1 inhibitor with an eye on cancer – Without properly functioning carbamoyl-phosphate synthetase I (CPS1), large amounts of highly toxic ammonia is able to accumulate in the body contributing to neurological conditions.2  Increased levels of the enzyme have been found in some cancers including lung adenocarcinoma (LADC).1 When overexpressed, CPS1 can eliminate ammonia from quickly proliferating cancer cells to aid in the growth of the tumor. Moreover, the enzyme plays a role in pyrimidine synthesis which also assists in tumor growth.3

The mechanisms of this are not completely understood at this time; however, the heterodimeric carbamoyl phosphate synthase (CPSase) enzyme produces carbamoyl phosphate which is the starting material for both urea and pyrimidines. In addition to carbamoyl phosphate, ADP is a byproduct of the ATP dependant phosphorylation.  An increase in CPS1 has been associated with a decreased survival probability and poorer prognosis in some cancer types.3

Due to research linking an abundance of CPS1 with cancer, Yao et al. set out to discover CPS1 inhibitors to treat cancer and gain more insight into the pathways involved.3 After first performing a high-throughput screening (HTS) followed by subsequent verification screenings, the scientists found a molecule to inhibit CPS1 without affecting the activity of carbamoyl phosphate synthetase II (CPS2). Both CPS1 and CPS2 enzymes have similar functions and are encoded by the same gene.3

Once the inhibitor, H3B-120, was discovered, additional assays were executed to further determine activity and functionality in relation to other proteins involved in pyrimidine synthesis. It’s not enough to discover a molecule to inhibit overexpressed CPS1 tumor cells, the inhibitor should not change the function of other proteins along the way.

Transcreener ADP CPS1 Inhibitor Assay

N-acetylglutamate (NAG) is a cofactor to CPS1 and without it, enzymatic activity is lower. The Transcreener® ADP² FP Assay was executed to examine the relationship between NAG and H3B-120. This assay has the ability to detect any enzyme that converts ATP to ADP.

Through various assay types, the researchers not only found a CPS1 inhibitor with the potential to treat specific cancers, but they were able to gain insight into how the inhibitor interacts within the pyrimidine synthesis pathway.

References

  1. Celiktas, M., Tanaka, I., Tripathi, S. C., Fahrmann, J. F., Aguilar-Bonavides, C., Villalobos, P., … Taguchi, A. (2017). Role of CPS1 in cell growth, metabolism, and prognosis in LKB1-inactivated lung adenocarcinoma. Journal of the National Cancer Institute, 109(3), 1–9. https://doi.org/10.1093/jnci/djw231
  2. Conditions, G. (n.d.). Genetics Home Reference CPS1 gene, 1–4. https://ghr.nlm.nih.gov/condition/carbamoyl-phosphate-synthetase-i-deficiency
  3. Yao, S., Nguyen, T.-V., Rolfe, A., Agrawal, A. A., Ke, J., Peng, S., … Bolduc, D. M. (2020). Small Molecule Inhibition of CPS1 Activity through an Allosteric Pocket. Cell Chemical Biology, 1–10. https://doi.org/10.1016/j.chembiol.2020.01.009
Tagged under: CPS1 Inhibitor, Synthetase Assay

What you can read next

Lipid Kinase Assay PI4K Inhibitor
Novartis Uses Lipid Kinase Assay in a Quest for a PI4K Inhibitor
Lab IRAK4 Inhibitors Kinase Assay Kit
Uncovering IRAK4 Inhibitors with a Transcreener Kinase Assay Kit
Success Story: Development of a High Throughput Screening Assay to Identify Inhibitors of the de novo Purine Biosynthetic Pathway

Categories

  • Company
  • Emerging Targets
  • Epigenetics
  • HTS Assays
  • Neurodegenerative Diseases
  • News
  • Products
  • Resources
  • Success Stories
  • Uncategorized

Recent Posts

  • Small GTPase Modulation

    Small GTPase Modulation: GDP Assays to Accelerate Discovery

    Cancer is complex, which makes determining the ...
  • TREX1 Press Release Graphic

    BellBrook Labs Receives NIH Funding for Novel Approach to Stimulating Antitumor Immunity

    The National Cancer Institute (NCI) recently aw...
  • Researcher Using An ADP Assay

    Accelerating Discovery of Kinase Inhibitors Using an ADP Assay

    An ADP assay can be used to study the activity ...
  • Inhibitors of ENPP1 SLAS Discovery

    New Publication by the Scientists at BellBrook Labs – Development of a High-Throughput Assay to Identify Inhibitors of ENPP1

    BellBrook scientist Meera Kumar and Robert Lowe...
  • GMP Assay for PDE Inhibitor Discovery

    Using a Universal GMP Assay for PDE Research

    A universal GMP assay to aid in PDE research an...

Archives

BellBrook Labs
5500 Nobel Drive, Suite 230
Madison, Wisconsin 53711 USA
(608) 443-2400

info@bellbrooklabs.com

 Copyright © 2019 BellBrook Labs | All Rights Reserved | Privacy Policy | Terms of Use | FCOI | Sitemap

TOP